Cite
HARVARD Citation
Olympios, N. et al. (n.d.). 242PImpact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). Annals of oncology. p. . [Online].